scispace - formally typeset
G

Gayasuddin Khan

Researcher at Indian Institutes of Technology

Publications -  20
Citations -  602

Gayasuddin Khan is an academic researcher from Indian Institutes of Technology. The author has contributed to research in topics: Bioavailability & Nanofiber. The author has an hindex of 14, co-authored 20 publications receiving 413 citations. Previous affiliations of Gayasuddin Khan include Indian Institute of Technology (BHU) Varanasi.

Papers
More filters
Journal ArticleDOI

Biomimetic PCL-gelatin based nanofibers loaded with ciprofloxacin hydrochloride and quercetin: A potential antibacterial and anti-oxidant dressing material for accelerated healing of a full thickness wound.

TL;DR: A PCL-gelatin based electrospun nanofibers enriched with quercetin and ciprofloxacin hydrochloride, confirmed its application for accelerated wound healing and confirmed the direct application of scaffold in the wounded area.
Journal ArticleDOI

Development and Evaluation of Biodegradable Chitosan Films of Metronidazole and Levofloxacin for the Management of Periodontitis

TL;DR: Clinical trials on patients proved the therapeutic efficacy of the films of MZ and LF by a significant (p < 0.05) decrease in the clinical markers of periodontitis, i.e. gingival index, plaque index and pocket depth.
Journal ArticleDOI

Tinidazole functionalized homogeneous electrospun chitosan/poly (ε-caprolactone) hybrid nanofiber membrane: Development, optimization and its clinical implications

TL;DR: Preliminary clinical trials on patients proved therapeutic efficacy of the developed nanofiber membrane by eliciting a significant (p<0.05) decrease in clinical markers of periodontitis.
Journal ArticleDOI

Ciprofloxacin HCl and quercetin functionalized electrospun nanofiber membrane: fabrication and its evaluation in full thickness wound healing

TL;DR: This study validates the application of ciprofloxacin HCl and quercetin functionalized nanofiber as a potential wound dressing material and demonstrates the capability of scaffold to suppress any probable infection and oxidative damage.
Journal ArticleDOI

Lipopolysaccharide based oral nanocarriers for the improvement of bioavailability and anticancer efficacy of curcumin.

TL;DR: Lipopolysaccharide nanocarriers show potential delivery strategy to improve oral bioavailability and anticancer efficacy of CUR in the treatment of colorectal cancer.